Skip to main content
ArticleOPEN ACCESS

Erratum: A brain penetrating bifunctional erythropoietin-transferrin receptor antibody fusion protein for alzheimer's disease (Molecular Pharmaceutics (2018) 15:11 (4963-4973) DOI: 10.1021/acs.molpharmaceut.8b00594)

Molecular Pharmaceutics
DOI: 10.1021/acs.molpharmaceut.9b01211
1Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

In our original article, the colors of the figure legends for Figure 2 for the APP/PS1-saline and APP/PS1-cTfRMAb- EPO were flipped. The correct version of Figure 2 is shown here. (Figure Presented).

Cite

CITATION STYLE

APA

Chang, R., Al Maghribi, A., Vanderpoel, V., Vasilevko, V., Cribbs, D. H., Boado, R., … Sumbria, R. K. (2020, January 6). Erratum: A brain penetrating bifunctional erythropoietin-transferrin receptor antibody fusion protein for alzheimer’s disease (Molecular Pharmaceutics (2018) 15:11 (4963-4973) DOI: 10.1021/acs.molpharmaceut.8b00594). Molecular Pharmaceutics. American Chemical Society. https://doi.org/10.1021/acs.molpharmaceut.9b01211

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free